These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9418768)

  • 1. Terbinafine: an update.
    Gupta AK; Shear NH
    J Am Acad Dermatol; 1997 Dec; 37(6):979-88. PubMed ID: 9418768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 3. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine: an oral and topical antifungal agent.
    Shear NH; Villars VV; Marsolais C
    Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
    [No Abstract]   [Full Text] [Related]  

  • 5. Terbinafine for onychomycosis.
    Med Lett Drugs Ther; 1996 Aug; 38(981):72-4. PubMed ID: 8699988
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients.
    Hall M; Monka C; Krupp P; O'Sullivan D
    Arch Dermatol; 1997 Oct; 133(10):1213-9. PubMed ID: 9382559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis.
    Kagawa S
    Clin Exp Dermatol; 1989 Mar; 14(2):114-5. PubMed ID: 2689013
    [No Abstract]   [Full Text] [Related]  

  • 9. Onychomycosis treated with a short course of oral terbinafine.
    Galimberti R; Kowalczuk A; Flores V; Squiquera L
    Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
    [No Abstract]   [Full Text] [Related]  

  • 10. Terbinafine, a unique oral antifungal: current perceptions.
    Jain S; Sehgal VN
    Int J Dermatol; 2000 Jun; 39(6):412-23. PubMed ID: 10944085
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.
    Drake LA; Shear NH; Arlette JP; Cloutier R; Danby FW; Elewski BE; Garnis-Jones S; Giroux JM; Gratton D; Gulliver W; Hull P; Jones HE; Journet M; Krol AL; Leyden JJ; Maddin SC; Ross JB; Savin RC; Scher RK; Sibbald GR; Tawfik NH; Zaias N; Tolpin M; Evans S; Birnbaum JE
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):740-5. PubMed ID: 9366820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal agents: an overview. Part II.
    Gupta AK; Sauder DN; Shear NH
    J Am Acad Dermatol; 1994 Jun; 30(6):911-33; quiz 934-6. PubMed ID: 7619094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new antifungal preparation Lamisil (terbinafine)].
    Eksp Klin Farmakol; 1993; 56(5):69-79. PubMed ID: 8312820
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole versus terbinafine in the management of onychomycosis: an overview.
    Jain S; Sehgal VN
    J Dermatolog Treat; 2003 Jan; 14(1):30-42. PubMed ID: 12745853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbinafine in onychomycosis of the toenail: a novel treatment protocol.
    Watson A; Marley J; Ellis D; Williams T
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):775-9. PubMed ID: 7593777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic antifungal agents used to treat onychomycosis.
    Katz HI
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S48-52. PubMed ID: 9594937
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
    Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases.
    Villars VV; Jones TC
    Br J Dermatol; 1992 Feb; 126 Suppl 39():61-9. PubMed ID: 1543676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.